dactinomycin has been researched along with AIDS-Related Opportunistic Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bezwoda, WR; Lachter, J; Spencer, D; Stein, ME | 1 |
1 other study(ies) available for dactinomycin and AIDS-Related Opportunistic Infections
Article | Year |
---|---|
Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dactinomycin; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Remission Induction; Retrospective Studies; Sarcoma, Kaposi; Skin Neoplasms; South Africa; Survival Rate; Treatment Failure; Treatment Outcome; Vinblastine; Vincristine | 1995 |